AKCEA THERAPEUTICS INC - COM (AKCA)

CUSIP: 00972L107

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
21,966,240
Share change
-1,654,511
Total reported value
$338,067,408
Put/Call ratio
127%
Price per share
$15.39
Number of holders
60
Value change
-$27,337,160
Number of buys
21
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 00972L107?
CUSIP 00972L107 identifies AKCA - AKCEA THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AKCEA THERAPEUTICS INC - COM (AKCA) as of Q3 2019

As of 30 Sep 2019, AKCEA THERAPEUTICS INC - COM (AKCA) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,966,240 shares. The largest 10 holders included FMR LLC, Bellevue Group AG, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, NORTHERN TRUST CORP, and Sculptor Capital LP. This page lists 60 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.